October 9, 2019
Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict — the largest jury award in the U.S. this year — over its alleged mishandling of an anti-psychotic drug blamed for causing adolescent boys to grow female-sized …
October 1, 2019
Endo International Plc, Johnson & Johnson and other drugmakers that face litigation over the opioid crisis are exploring a way to settle the cases by participating in Purdue Pharma LP’s bankruptcy, the Wall Street Journal reported, citing internal documents and …
June 19, 2019
An online pharmacy told U.S. regulators it found another cancer-causing chemical in widely prescribed blood-pressure pills, raising new questions about a complex global web of companies that produces medicine for millions of people. A solvent called dimethylformamide was discovered in …
April 24, 2019
Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens, the first claims in what some lawyers expect to be a wave of litigation. Millions of Americans have taken …
March 26, 2019
Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits alleging that their blockbuster blood thinner Xarelto caused unstoppable and in some cases fatal bleeding for a total of $775 million, court documents on Monday …
March 6, 2019
A lawsuit claiming Purdue Pharma engaged in deceptive marketing to increase opioid prescriptions, resulting in an epidemic, has the go-ahead from a Knox County judge. The lawsuit brought by the state of Tennessee claims Purdue‘s marketing violates the Tennessee Consumer …
March 4, 2019
OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from thousands of lawsuits alleging the drug manufacturer contributed to the deadly opioid crisis sweeping the United States, people familiar with the matter said on …
July 6, 2018
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. U.S. …
March 27, 2018
A U.S. jury on Monday ordered AbbVie Inc. to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury …
January 10, 2018
A Pennsylvania state court judge on Tuesday overturned a $27.8 million jury award to an Indiana couple who accused Bayer AG and Johnson & Johnson of failing to warn of internal bleeding risks of their drug Xarelto, the companies said. …